Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy.

Autor: Li JZ; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Chapman B; Harvard School of Public Health, Boston, Massachusetts, United States of America., Charlebois P; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America., Hofmann O; Harvard School of Public Health, Boston, Massachusetts, United States of America., Weiner B; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America., Porter AJ; Harvard School of Public Health, Boston, Massachusetts, United States of America., Samuel R; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Virology, University of KwaZulu-Natal, National Health Laboratory Service, Durban, South Africa., Vardhanabhuti S; Harvard School of Public Health, Boston, Massachusetts, United States of America., Zheng L; Harvard School of Public Health, Boston, Massachusetts, United States of America., Eron J; Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America., Taiwo B; Division of Infectious Diseases, Northwestern University, Chicago, Illinois, United States of America., Zody MC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America., Henn MR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America., Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Hide W; Harvard School of Public Health, Boston, Massachusetts, United States of America., Wilson CC; University of Colorado., Berzins BI; Northwestern University., Acosta EP; University of Alabama at Birmingham., Bastow B; ACTG Operations Center, Social & Scientific Systems, Inc., Kim PS; National Institute of Allergy and Infectious Diseases., Read SW; National Institute of Allergy and Infectious Diseases., Janik J; Frontier Science & Technology Research Foundation., Meres DS; National Institute of Allergy and Infectious Diseases., Lederman MM; Case Western Reserve University., Mong-Kryspin L; Ohio State University., Shaw KE; Henry Ford Hospital CRS., Zimmerman LG; University of Colorado CRS., Leavitt R; Merck., De La Rosa G; Tibotec., Jennings A; ACTG Operations Center.

Publikováno v: PloS one [PLoS One] 2014 Mar 06; Vol. 9 (3), pp. e90485. Date of Electronic Publication: 2014 Mar 06 (Print Publication: 2014).